Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP405406.RAJgkdLeiJR3aEcw4xgitIY3O5XnJtIvGyB8Hu9_AZayo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP405406.RAJgkdLeiJR3aEcw4xgitIY3O5XnJtIvGyB8Hu9_AZayo130_assertion type Assertion NP405406.RAJgkdLeiJR3aEcw4xgitIY3O5XnJtIvGyB8Hu9_AZayo130_head.
- NP405406.RAJgkdLeiJR3aEcw4xgitIY3O5XnJtIvGyB8Hu9_AZayo130_assertion description "[Thus, Akt and FoxO1, in addition to the well-known EGFR, appear to be promising therapeutic targets for preventing the metastasis of NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP405406.RAJgkdLeiJR3aEcw4xgitIY3O5XnJtIvGyB8Hu9_AZayo130_provenance.
- NP405406.RAJgkdLeiJR3aEcw4xgitIY3O5XnJtIvGyB8Hu9_AZayo130_assertion evidence source_evidence_literature NP405406.RAJgkdLeiJR3aEcw4xgitIY3O5XnJtIvGyB8Hu9_AZayo130_provenance.
- NP405406.RAJgkdLeiJR3aEcw4xgitIY3O5XnJtIvGyB8Hu9_AZayo130_assertion SIO_000772 24705809 NP405406.RAJgkdLeiJR3aEcw4xgitIY3O5XnJtIvGyB8Hu9_AZayo130_provenance.
- NP405406.RAJgkdLeiJR3aEcw4xgitIY3O5XnJtIvGyB8Hu9_AZayo130_assertion wasDerivedFrom befree-20150227 NP405406.RAJgkdLeiJR3aEcw4xgitIY3O5XnJtIvGyB8Hu9_AZayo130_provenance.
- NP405406.RAJgkdLeiJR3aEcw4xgitIY3O5XnJtIvGyB8Hu9_AZayo130_assertion wasGeneratedBy ECO_0000203 NP405406.RAJgkdLeiJR3aEcw4xgitIY3O5XnJtIvGyB8Hu9_AZayo130_provenance.